Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

First Successful Transplant of Heart of a Genetically-modified (GM) Pig into Human

Doctors and scientists of University of Maryland School of Medicine have successfully transplanted heart of a genetically engineered pig (GEP) into an adult patient with end-stage heart disease. This surgery was patient’s only option left for survival after being found ineligible for traditional transplant. The patient is doing well three days after the procedure.  

This is the first time that a genetically-engineered animal heart has functioned like a human heart without immediate rejection by the body. 

Xenotransplants (i.e., organ transplant from animal to human) were first tried in the 1980s, but were largely abandoned due to the immune system’s rejection of the foreign heart however pig heart valves have been used successfully for replacing valves in humans

In this case, the donor pig had been genetically modified to avoid rejection. A total of ten gene edits were made in the donor pig – three genes responsible for rapid rejection of pig organs by human were deleted, six human genes responsible for immune acceptance of the pig heart were inserted in the genome of the donor pig and one additional gene in the pig responsible for excessive growth of the heart tissue was removed.  

This surgery is very significant because this brings us one step closer to solving the organ shortage crisis through use of genetically engineered animal donors to avoid immune rejection by the human recipient.  

***

Reference:  

University of Maryland School of Medicine. News – University of Maryland School of Medicine Faculty Scientists and Clinicians Perform Historic First Successful Transplant of Porcine Heart into Adult Human with End-Stage Heart Disease. Posted January 10, 2022. Available at https://www.medschool.umaryland.edu/news/2022/University-of-Maryland-School-of-Medicine-Faculty-Scientists-and-Clinicians-Perform-Historic-First-Successful-Transplant-of-Porcine-Heart-into-Adult-Human-with-End-Stage-Heart-Disease.html  

***

SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

Risk of Dementia & Moderate Alcohol Consumption

VIDEO Like if you enjoyed the video, subscribe to Scientific...

COVID-19, Immunity & Honey: Recent Advances in Understanding Medicinal Properties of Manuka Honey

Anti-viral properties of manuka honey are due to the...

HIV/AIDS: mRNA Vaccine Shows Promise in Pre-clinical Trial  

Successful development of mRNA vaccines, BNT162b2 (of Pfizer/BioNTech) and...
- Advertisement -
93,340FansLike
47,367FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe